Initial Statement of Beneficial Ownership (3)
December 08 2017 - 4:35PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Mowery Andrew J
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/1/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
CLOROX CO /DE/ [CLX]
|
(Last)
(First)
(Middle)
1221 BROADWAY
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
SVP-Chief Product Supply /
|
(Street)
OAKLAND, CA 94612-1888
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
3047.0000
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (Right to Buy)
|
9/15/2010
(1)
|
9/15/2019
|
Common Stock
|
6270.0000
|
$57.2500
|
D
|
|
Stock Option (Right to Buy)
|
9/14/2011
(1)
|
9/14/2020
|
Common Stock
|
6990.0000
|
$66.4800
|
D
|
|
Stock Option (Right to Buy)
|
9/13/2012
(1)
|
9/13/2021
|
Common Stock
|
6100.0000
|
$68.1500
|
D
|
|
Stock Option (Right to Buy)
|
9/11/2013
(1)
|
9/11/2022
|
Common Stock
|
8120.0000
|
$72.1100
|
D
|
|
Stock Option (Right to Buy)
|
9/17/2014
(1)
|
9/17/2023
|
Common Stock
|
6110.0000
|
$84.4500
|
D
|
|
Stock Option (Right to Buy)
|
9/17/2015
(1)
|
9/17/2024
|
Common Stock
|
16930.0000
|
$89.8200
|
D
|
|
Stock Option (Right to Buy)
|
9/15/2016
(1)
|
9/15/2025
|
Common Stock
|
12360.0000
|
$111.6000
|
D
|
|
Stock Option (Right to Buy)
|
9/13/2017
(1)
|
9/13/2026
|
Common Stock
|
11830.0000
|
$123.0900
|
D
|
|
Stock Option (Right to Buy)
|
9/12/2018
(1)
|
9/12/2027
|
Common Stock
|
10650.0000
|
$135.5700
|
D
|
|
Explanation of Responses:
|
(1)
|
Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Mowery Andrew J
1221 BROADWAY
OAKLAND, CA 94612-1888
|
|
|
SVP-Chief Product Supply
|
|
Signatures
|
By Cheryl Brice, Attorney-in-Fact for
|
|
12/8/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Clorox (NYSE:CLX)
Historical Stock Chart
From Apr 2024 to May 2024
Clorox (NYSE:CLX)
Historical Stock Chart
From May 2023 to May 2024